News

Under the terms of the agreement, GlaxoSmithKline will exclusively promote Diastat and Diastat AcuDial to US physicians in 2009, with an option to extend the term by mutual

With the approved CE Mark for Uracyst already in place for the European market, Eczacibasi Ilac Pazarlama (EIP) has agreed to obtain all necessary regulatory approvals at its

The combination of the two businesses will take place by a share exchange and create a European company in the field of discovery and development of therapeutics for

The company has also appointed David DeMagistris as senior vice president of pharmaceutical sciences and Jean Silveri as senior vice president of general counsel. Prior to joining Cerulean,

The positive opinion includes important survival data from the AZA-001 trial in higher-risk myelodysplastic syndromes (MDS) patients. The Committee for Medicinal Products for Human Use (CHMP), which reviews

This FDA approval represents the first for a bronchial valve implant for the lungs. The FDA humanitarian device exemption (HDE) approval of the IBV valve system is based

In the study, oritavancin activity at 10, 50 and 100mg/kg/day and a pegylated (PEG400) formulation of oritavancin at 100mg/kg/day were compared to vancomycin activity at 50mg/kg/day against clindamycin-induced

The open-label trial met both its primary (efficacy) and secondary (safety) endpoints. All doses of radezolid were as efficacious as linezolid and demonstrated a good safety profile. The

According to the company, the Vitros 5600 integrated system is designed to integrate clinical chemistry and immunoassay testing to increase laboratory productivity and will be able to perform